M. Xue

发表

Clinical Significance of Peripheral Blood Lymphocyte Subtypes and Cytokines in Patients with Hepatocellular Carcinoma Treated with TACE

Hongyu Wang, Guixiong Zhang, W. Fan, 2022, Cancer management and research.

Non-Apoptotic Programmed Cell Death-Related Gene Signature Correlates With Stemness and Immune Status and Predicts the Responsiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma

Hongyu Wang, Guixiong Zhang, W. Fan, 2022, Frontiers in Cell and Developmental Biology.

Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization

W. Fan, M. Xue, Bowen Zhu, 2022, Journal of Cancer Research and Clinical Oncology.

Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis

Hongyu Wang, W. Fan, Yanqin Wu, 2022, Cancer medicine.

Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.

W. Fan, Yanqin Wu, M. Xue, 2019, Clinical therapeutics.

Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma

Hongyu Wang, W. Fan, Yanqin Wu, 2020, Cancer research and treatment : official journal of Korean Cancer Association.

Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS

Hongyu Wang, W. Fan, Yanqin Wu, 2021, European Radiology.

Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.

Shenghong Zhang, W. Fan, Yanqin Wu, 2019, The oncologist.

25-OH-vitamin D deficiency identifies poor tumor response in hepatocellular carcinoma treated with transarterial chemoembolization

W. Fan, M. Xue, W. Yao, 2019, Clinical and Translational Oncology.

CMAR_A_304591 4013..4029

W. Fan, M. Xue, Jiaping Li, 2021 .

Advanced hepatocellular carcinoma treated by transcatheter arterial chemoembolization with drug-eluting beads plus lenvatinib versus sorafenib, a propensity score matching retrospective study.

W. Fan, Yanqin Wu, M. Xue, 2021, American journal of cancer research.

Combined Use of Transjugular Intrahepatic Portosystemic Shunt and Transarterial Chemoembolization in the Treatment of Esophageal and Gastric Variceal Bleeding: A Retrospective Study of 80 Patients with Hepatocellular Carcinoma and Portal Hypertension

M. Xue, Jiaping Li, Xinhua Zou, 2021, Medical science monitor : international medical journal of experimental and clinical research.

Silencing SAPCD2 Represses Proliferation and Lung Metastasis of Fibrosarcoma by Activating Hippo Signaling Pathway

Hongyu Wang, W. Fan, Yanqin Wu, 2020, Frontiers in Oncology.

A 10-Gene Signature Identified by Machine Learning for Predicting the Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma

W. Fan, Yanqin Wu, M. Xue, 2022, Journal of oncology.

Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy

W. Fan, Yanqin Wu, M. Xue, 2020, Frontiers in Oncology.

Association between urinary VEGFA and renal pathology of IgA nephropathy patients

M. Xue, Q. Guo, Zhijian Li, 2021, Journal of clinical laboratory analysis.

Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization

Hongyu Wang, W. Fan, Yanqin Wu, 2022, Journal of Cancer Research and Clinical Oncology.

Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression

W. Fan, M. Xue, Jiaping Li, 2021, Cancer management and research.

Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study

Yu Cheng, Zhen Huang, Hongyu Wang, 2022, European Radiology.

Identification of BRD7 by whole-exome sequencing as a predictor for intermediate-stage hepatocellular carcinoma in patients undergoing TACE

W. Fan, Yanqin Wu, M. Xue, 2023, Journal of Cancer Research and Clinical Oncology.

Clinical Significance of Peripheral Blood Lymphocyte Subtypes and Cytokines in Patients with Hepatocellular Carcinoma Treated with TACE

Hongyu Wang, Guixiong Zhang, W. Fan, 2022 .

Integrated machine learning screened glutamine metabolism-associated biomarker SLC1A5 to predict immunotherapy response in hepatocellular carcinoma.

Guixiong Zhang, Yanqin Wu, M. Xue, 2024, Immunobiology.